LABORATORY RESEARCH Estrogen Receptor (ESR1) mRNA Expression and Benefit from Tamoxifen in the Treatment and Prevention of Estrogen Receptor–Positive Breast Cancer Researchers used gene expression profiling and estrogen receptor protein assays to help elucidate molecular mechanism(s) responsible for tamoxifen resistance in breast tumors. [J Clin Oncol] Abstract Reduced miR-128 in Breast Tumor-Initiating Cells Induces Chemotherapeutic Resistance via Bmi-1 and ABCC5 Lentivirus-mediated microRNA (miR)-128 transduction was performed in breast tumor-initiating cells, enriched by mammosphere cultures or CD44+CD24– FACS (Fluorescence Activated Cell Sorting). [Clin Cancer Res] Abstract G1P3, an Interferon- and Estrogen-Induced Survival Protein Contributes to Hyperplasia, Tamoxifen Resistance and Poor Outcomes in Breast Cancer Here investigators elucidate G1P3, a survival protein induced by interferons, as a target of estrogen signaling and a contributor to poor outcomes in estrogen receptor-positive breast cancer. [Oncogene] Abstract The BMP2/7 Heterodimer Inhibits the Human Breast Cancer Stem Cell Subpopulation and Bone Metastases Formation Here, scientists studied the effects of bone morphogenetic protein-7 (BMP7), BMP2 and a BMP2/7 heterodimer on the formation of human breast cancer stem cells (ALDHhi/CD44hi/CD24−/low) and bone metastases formation in a preclinical model of intra-cardiac injection of MDA-MB-231 cells in athymic nude mice. [Oncogene] Abstract Heterogeneity in MYC-Induced Mammary Tumors Contributes to Escape from Oncogene Dependence Researchers made use of a Myc-inducible transgenic mouse model of breast cancer in which elimination of Myc activity following tumor development initially leads to a regression of a subset of tumors generally followed by de novo Myc-independent growth. [Oncogene] Abstract CD49f and CD61 Identify Her2/Neu-Induced Mammary Tumor-Initiating Cells That Are Potentially Derived from Luminal Progenitors and Maintained by the Integrin–TGFβ Signaling Through systematic screening and characterization, investigators identified that surface markers CD49f, CD61 and ESA were aberrantly overexpressed in human epidermal growth factor receptor 2 (HER2)-overexpressing mammary tumor cells. [Oncogene] Abstract Generation of Tumor Initiating Cells by Exogenous Delivery of OCT4 Transcription Factor Herein, scientists describe the generation of tumor initiating cell-like cell lines by ectopic expression of the OCT4 transcription factor in primary breast cell preparations. [Breast Cancer Res] Abstract CLINICAL RESEARCH Determining True HER2 Gene Status in Breast Cancers with Polysomy By Using Alternative Chromosome 17 Reference Genes: Implications for Anti-HER2 Targeted Therapy This study tests the hypothesis that the use of alternative chromosome 17 reference genes might more accurately assess true HER2 gene status. [J Clin Oncol] Abstract Phase I Trial of Adoptive Cell Transfer with Mixed-Profile Type-I/Type-II Allogeneic T Cells for Metastatic Breast Cancer This Phase-I translational study evaluated adoptive transfer of ex vivo-costimulated Type-I/Type-II donor T cells with T-cell-depleted allogeneic stem-cell transplantation for metastatic breast cancer. [Clin Cancer Res] Abstract |